DUAL DIAGNOSIS TREATMENT CENTER, INC. v. HORIZON BLUE CROSS AND BLUE SHIELD OF NEW JERSEY

District Court, D. New Jersey·Decided April 19, 2022·No. 2:20-cv-15285·Unknown

Opinion

NOT FOR PUBLICATION

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY

DUAL DIAGNOSIS TREATMENT CENTER, INC. d/b/a SOVEREIGN HEALTH OF CALIFORNIA; SHREYA HEALTH OF Civil Action No. 20-15285 (SDW)(AME) CALIFORNIA, INC.; MEDICAL CONCIERGE, INC. d/b/a/ MEDLINK; SATYA HEALTH OF CALIFORNIA, INC.; and VEDANTA LABORATORIES, INC., OPINION

Plaintiffs,

v. April 19, 2022

HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY and HORIZON HEALTHCARE SRVICES, INC.,

Defendants.

WIGENTON, District Judge. Before this Court is Defendant Horizon Healthcare Services, Inc.’s1 (“Defendant”) Motion to Dismiss (D.E. 27-1) Plaintiffs Dual Diagnosis Treatment Center, Inc. d/b/a Sovereign Health of California (“Dual Diagnosis”), Shreya Health of California, Inc. (“Shreya”), Medical Concierge, Inc. d/b/a Medlink (“Medlink”), Satya Health of California, Inc. (“Satya”), and Vedanta Laboratories, Inc.’s (“Vedanta,” and collectively “Plaintiffs”) Third Amended Complaint (D.E. 23 (“Compl.”)) pursuant to Federal Rule of Civil Procedure (“Rule”) 12(b)(6). Jurisdiction is proper pursuant to 28 U.S.C. § 1332. Venue is proper pursuant to 28 U.S.C. §§ 1441(a) and 1445(a).

1 Although Plaintiffs named “Horizon Blue Cross Blue Shield of New Jersey” and “Horizon Healthcare Services, Inc.” as separate parties, Defendant asserts that the former is the trade name of the latter. (D.E. 27-1 at 1, n.1.) This opinion is issued without oral argument pursuant to Rule 78. For the reasons stated below, Defendant’s Motion is GRANTED with prejudice. I. FACTUAL HISTORY Plaintiffs are for-profit substance abuse and mental health treatment centers based in

California. (Compl. ¶¶ 2, 11-16, 28.) Plaintiffs rendered out-of-network behavioral health treatment services to eleven patients (the “Patients”), who were allegedly insured under Defendant’s “employee benefit plan[s].” (See id. ¶¶ 1, 10, 17-22); see 29 U.S.C. § 1002(3). Plaintiffs claim that they verified the scope of the Patients’ substance abuse or mental health coverage and the logistics of securing authorization and payment with Defendant. (Compl. ¶¶ 31- 34.) Plaintiffs aver that they were owed between 50-70% of the billed charges depending on each individual plan and the services provided. (Id. ¶¶ 37.) After completing the insurance verification process, Plaintiffs contacted the Patients to discuss their policies and make any necessary arrangements. (Id. ¶ 35.) Plaintiffs allege that they obtained valid benefit assignments (“Assignments”), and in some instances, a Designation of Authorized Representatives, from all

Patients before treatment. (Id. ¶¶ 47-49.) At the time Shreya, Vedanta, Medlink, and Satya rendered services to the Patients, all Patients were covered under either a Horizon policy or a self-funded plan administered by Horizon. (Id. ¶¶ 51- 152.) In addition to the Assignments from Patients, Plaintiffs allege that they contacted Defendant directly to get details of the type of coverage that each patient had under their individualized plans and the payments required to be made under the plans. (Id. ¶¶ 55, 64, 73, 84, 93, 104, 112, 120, 128, 139, 148.) Plaintiffs further alleged that the Patients’ individual plans provided, inter alia, the coverage for out-of-network behavioral services; precertification requirements for certain levels of care; applicable patient deductibles; billing codes covered under the plan; and percentage amount that the plan will pay for out-of-network services and laboratory services. (Id. ¶¶ 56, 65, 74, 85, 94, 105, 113, 121, 129, 140, 149.) Plaintiffs allege that despite repeated requests for the plan documents to be provided to Plaintiffs or the Patients, Defendant never provided such documents. (Id. ¶¶ 57-150.)

In accordance with the plans, Plaintiffs allege that they provided medically necessary services to the Patients. (Id. ¶ 153.) Plaintiffs then notified Defendant of these Assignments and then submitted claims. (Id. ¶ 154.) Plaintiffs assert that Defendant never informed Plaintiffs that they would not honor the Assignments, but instead approved and authorized payments directly to the Patients. (Id. ¶¶ 166, 169.) Defendant allegedly refused to pay or underpaid substantial benefits. (Id. ¶¶ 58, 67, 76, 87, 96, 107, 115, 123, 131, 142, 151, 171.) Plaintiffs further contend that Defendant “improperly paid only a fraction of the billed charges for the particular medical services.” (Id. ¶173-174, 176.) Plaintiffs contend that Defendant’s behavior was misleading, risked the health and safety of the Patients, and guaranteed that Plaintiffs would not receive what they were owed for their services. (Id. ¶ 172.)

II. PROCEDURAL HISTORY Plaintiffs filed their original Complaint on October 30, 2020. (D.E. 1.) On November 23, 2020, Plaintiffs filed an Amended Complaint. (D.E. 3.) Defendant moved to dismiss on January 29, 2021, but withdrew the motion on March 4, 2021. (D.E. 9.) Plaintiffs filed their Second Amended Complaint on March 15, 2021, claiming benefits under the Employment Retirement Income Security Act of 1974 (“ERISA”) § 502 (“Section 502”). (D.E. 15.) Defendant moved to dismiss again on April 14, 2021. (D.E. 18-1.) On July 9, 2021, this Court issued an Opinion and Order dismissing Plaintiffs’ Second Amended Complaint without prejudice. (D.E. 21, 22.) Plaintiffs’ Second Amended Complaint was dismissed for failing to state a claim under Section 502 because “the Complaint failed to provide plausible evidence that each of the Plaintiffs is an assignee for, at absolute minimum, one Patient.” (D.E. 21 at 5.) The Second Amended Complaint was also dismissed for failing to state a claim under Section 502 because it contained only conclusory statements regarding plan terms that align with the alleged benefits. (D.E. 21 at 6.)

Plaintiffs were permitted to file a Third Amended Complaint. (D.E. 21 at 7.) Additionally, Plaintiffs were advised that “additional amendments would not be authorized.” (D.E. 21 at 7.) Plaintiffs filed their Third Amended Complaint on July 30, 2021 claiming benefits under ERISA Section 502. (D.E. 23.) Defendant moved to dismiss the Third Amended Complaint again on September 10, 2021. (D.E. 27.) All subsequent briefing was timely filed. (D.E. 32, (“Opp. Br.”); D.E. 33.) III. STANDARD OF REVIEW To survive a motion to dismiss under Rule 12(b)(6), a complaint must include “a short and plain statement of the claim showing that the pleader is entitled to relief.” Rule 8(a)(2). This Rule “requires more than labels and conclusions, and a formulaic recitation of the elements of a cause

Free access — add to your briefcase to read the full text and ask questions with AI

DUAL DIAGNOSIS TREATMENT CENTER, INC. v. HORIZON BLUE CROSS AND BLUE SHIELD OF NEW JERSEY, (D.N.J. 2022).

DUAL DIAGNOSIS TREATMENT CENTER, INC. v. HORIZON BLUE CROSS AND BLUE SHIELD OF NEW JERSEY (DUAL DIAGNOSIS TREATMENT CENTER, INC. v. HORIZON BLUE CROSS AND BLUE SHIELD OF NEW JERSEY) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Phillips v. County of Allegheny
515 F.3d 224 (Third Circuit, 2008)
Fowler v. UPMC SHADYSIDE
578 F.3d 203 (Third Circuit, 2009)
Hooven v. Exxon Mobil Corp.
465 F.3d 566 (Third Circuit, 2006)
Spokeo, Inc. v. Robins
578 U.S. 330 (Supreme Court, 2016)